Advancements like development of immunoconjugate drugs, multi-targeted receptor tyrosine kinase inhibitors, epidermal growth factor receptor inhibitors are expected to improve treatment efficacy and outcomes in head and neck cancer patients. https://www.newsanalyticspro.com/head-and-neck-cancer-drugs-market-is-estimated-to-witness-high-growth-owing-to-increasing-incidence-of-head-and-neck-cancer-and-growing-rd-activities/